Close

Notable Analyst Rating Changes 06/25: (MRVL) (LVS) (LRCX) Upgraded; (NFLX) (PAAS) (DMD) Downgraded

June 25, 2013 10:49 AM EDT
UPGRADES
Brean Capital raises Marvell (Nasdaq: MRVL) from Hold to Buy with a price target of $13.

Craig-Hallum upgrades Las Vegas Sands (NYSE: LVS) from Neutral to Buy with a price target of $59. Click Here for more color.

CLSA moves Lam Research (Nasdaq: LRCX) from Underperform to Outperform, adjusting its price target from $50 up to $55.

Hilliard Lyons boosts Zoetis Inc. (NYSE: ZTS) from Neutral to Buy.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Bernstein downgrades Netflix (Nasdaq: NFLX) from Market Perform to Underperform, moving its price target from $125 up to $180.

Demand Media (NYSE: DMD) downgraded by two today:
  • JMP Securities from Market Outperform to Market Perform; and

  • Stifel Nicolaus from Buy to Hold.

Cowen cuts Pan Am Silver (Nasdaq: PAAS) from Outperform to Market Perform.

William Blair trims Titan Machinery (Nasdaq: TITN) from Outperform to Market Perform.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Epizyme (Nasdaq: EPZM) started by several firms Tuesday:
  • Citi at Buy and $32 price target;

  • Cowen with an Outperform;

  • JMP Securities at Market Outperform;

  • Leerink Swann at Outperform and price target of $34.

First Analysis initiates coverage on Intuitive Surgical (Nasdaq: ISRG) with an Equal Weight.

William Blair assumes Francesca's Holdings (Nasdaq: FRAN) at Outperform.

Piper Jaffray starts Mast Therapeutics (NYSE: MSTX) with an Overweight and $1 price target.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Piper Jaffray, Stifel, William Blair, Citi, JMP Securities, First Analysis, Hilliard Lyons, Notable Analyst Rating Changes, Cowen & Co